NASDAQ: IRDOpus Genetics Inc Stock Ownership - Who owns Opus Genetics?
Insider buying vs selling
Have Opus Genetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Foundation Fighting Blindness Retinal Degeneration Fund | Director | 2026-05-18 | 1,700,000 | $4.35 | $7.39MSell |
| Benjamin R. Yerxa | President | 2026-04-23 | 7,470 | $5.24 | $39.12kSell |
| Joseph K. Schachle | Chief Operating Officer | 2026-04-23 | 4,697 | $5.22 | $24.52kSell |
| Ashwath Jayagopal | Chief Scientific Dev. Ofc. | 2026-04-23 | 7,542 | $5.19 | $39.16kSell |
| Rabourn Amy Zaremba | Head of Fin. Quality Assurance | 2026-04-23 | 1,641 | $5.20 | $8.54kSell |
| George Magrath | Chief Executive Officer | 2026-04-23 | 9,511 | $5.22 | $49.65kSell |
| Robert E. Gagnon | Chief Financial Officer | 2026-04-23 | 7,842 | $5.19 | $40.66kSell |
| Ashwath Jayagopal | Chief Scientific Dev. Ofc. | 2026-03-16 | 3,719 | $5.12 | $19.04kSell |
| Rabourn Amy Zaremba | Head of Fin. Quality Assurance | 2026-03-16 | 2,816 | $5.25 | $14.77kSell |
| George Magrath | Chief Executive Officer | 2026-03-16 | 24,438 | $5.21 | $127.32kSell |
IRD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IRD insiders and whales buy or sell their stock.
IRD Shareholders
What type of owners hold Opus Genetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sungkee Chung | 201.24% | 163,800,000 | $727.27M | Insider |
| Sung Sook Park | 86.25% | 70,200,000 | $311.69M | Insider |
| Frank Ferraro | 31.94% | 26,000,000 | $115.44M | Insider |
| Inok Ahn | 17.20% | 14,000,000 | $62.16M | Insider |
| Chang Ho Ahn | 14.14% | 11,510,000 | $51.10M | Insider |
| Caligan Partners LP | 7.46% | 6,075,028 | $26.97M | Institution |
| Adage Capital Partners GP LLC | 7.41% | 6,029,775 | $26.77M | Institution |
| Rexgene Biotech Co Ltd | 6.76% | 5,505,956 | $24.45M | Insider |
| Foundation Fighting Blindness Retinal Degeneration Fund | 4.66% | 3,792,171 | $16.84M | Insider |
| Bios Capital Management LP | 4.53% | 3,683,429 | $16.35M | Institution |
IRD vs Biotech Stocks
Opus Genetics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.